GlobeNewswire by notified

Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group

Share

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group (“Negma”) has by notice to Mendus requested the conversion of convertible bonds that have been issued to Negma in accordance with the financing agreement announced by Mendus through press releases on 26 August and 26 October 2022.

Negma has requested conversion of 22 convertible bonds issued on 3 January 2023, corresponding to SEK 550,000 of the convertible loan amounting to a total of SEK 13,400,000, into 249,999 shares. Upon registration at the Swedish Companies Registration Office, Mendus’ total share capital will amount to SEK 9,988,627,45 and the total number of shares and votes will amount to 199,772,549.

The conversion price per share is SEK 2.20, equivalent to 92% of the lowest closing volume weighted average share price (VWAP) of the 10 consecutive trading days preceding the issuance of conversion request by Negma.

For further information regarding the convertible bonds issued on 3 January 2023, please refer to the press release published on 5 January 2023.

Please refer to the section “Convertible Bonds” of the Investors page at Mendus’ website for a summary of all outstanding convertible bonds and issued shares upon conversion in regard to the financing agreement with Negma.


FOR MORE INFORMATION, PLEASE CONTACT:
Erik Manting

Chief Executive Officer

E-mail: ir@mendus.com


INVESTOR RELATIONS
Corey Davis

LifeSci Advisors, LLC

Telephone: + 1 212-915-2577

E-mail: cdavis@lifesciadvisors.com


MEDIA RELATIONS
Mario Brkulj

Valency Communications

Telephone: +49 160 9352 9951

E-mail: mbrkulj@valencycomms.eu


ABOUT MENDUS AB (PUBL)

Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST. http://www.mendus.com/

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Transactions by persons discharging managerial responsibilities29.3.2023 08:45:00 CEST | Press release

Company Announcement no. 122– 2023 Copenhagen, March29th, 2023 Transactions by persons discharging managerial responsibilities Pursuant to the EU Market Abuse Regulation, GreenMobility A/S hereby reports transactions made in GreenMobility A/S shares by persons obliged to report on transactions to the Danish FSA and Nasdaq Copenhagen Main Market. Tue Østergaard, Chairman of the board, has purchased 57 shares in GreenMobility A/S, resulting in a total holding of 16,050 shares For further details, please refer to the attached forms for notification and public disclosure of transactions performed by persons with managerial responsibilities and persons closely associated with them. Contact and further information Anders Wall, Group CFO, +45 25 40 30 20, e-mail: aw@greenmobility.com About GreenMobility GreenMobility offers modern urbanites easy, flexible, and sustainable transport in the form of electric shared city cars. Users have access to these cars via the GreenMobility app. Trips are p

Invitation Annual General Meeting Fenix Outdoor International AG29.3.2023 08:30:00 CEST | Press release

Invitation to the ordinary General Meeting of Shareholders of Fenix Outdoor International AG Dear Shareholder, The Board of Directors is pleased to invite you to the ordinary General Meeting concerning the financial year 2022 Date: Friday, April 21 2023, 2 pm Place: Hemvärnsgatan 9, Solna (Sweden) I. Notification Shareholders who wish to attend (in person, representation by proxy or by the Independent Proxy) the ordinary General Meeting must be recorded in the Company's share register by Thursday, 13 April 2023 at the latest and must notify the Company no later than Tuesday, 18 April 2023, 1 p.m. by telephone +46 660 26 62 00, by mail to Fenix Outdoor International AG, Hemvärnsgatan 15, 171 54 Solna (Sweden) or by e-mail info@fenixoutdoor.se of their attendance. An e-mail from the Company confirming the receipt of the notification must be presented at the entrance in order to be admitted to the ordinary General Meeting. The notification of the Shareholder must include name, personal id

Fenix Outdoor International AG Kallelse Årsstämma29.3.2023 08:30:00 CEST | Pressemelding

Kallelse till årsstämma för aktieägarei Fenix Outdoor International AG Kära aktieägare, Styrelsen inbjuder er härmed till årsstämma för räkenskapsåret 2022. Datum: Fredagen den 21 april 2023, kl. 14:00 Place: Hemvärnsgatan 9, Solna (Sverige) I. Anmälan Aktieägare som önskar att delta (personligen, genom ombud eller genom det oberoende ombudet) på årsstämman måste vara införd i bolagets aktiebok senast torsdagen den 13 april 2023 och anmäla sitt deltagande till bolaget senast tisdagen den 18 april 2023 kl. 13 00 på telefon +46 660 26 62 00, per post till Fenix Outdoor International AG, Hemvärnsgatan 15, 171 54 Solna, Sverige eller genom e-mail till info@fenixoutdoor.se. Ett e-mail från bolaget som bekräftar mottagande av anmälan, måste uppvisas vid entrén för tillträde till årsstämman. Aktieägarens anmälan måste innehålla namn, personnummer (organisationsnummer), adress, e-postadress (om tillämpligt), telefonnummer och namnet på eventuella medföljande biträden. Aktieägare som har sina a